Agency Forms Undergoing Paperwork Reduction Act Review, 76733-76736 [2011-31562]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 236 / Thursday, December 8, 2011 / Notices
availability of various economic factors
affecting product cost and supply.
The ACBSA consists of 20 voting
members. The Committee is composed
of 14 public members, including the
Chair, and six (6) representative
members. The public members are
selected from State and local
organizations, advocacy groups,
provider organizations, academic
researchers, ethicists, private
physicians, scientists, consumer
advocates, legal organizations, and from
among communities of persons who are
frequent recipients of blood or blood
products. The six individuals who are
appointed as official representative
members are selected to serve the
interests of the blood and blood
products industry or professional
organizations associated with
transfusion or transplantation safety.
The representative members are selected
from the following groups: The AABB,
the plasma protein fraction community,
one of the two major distributors of
blood on a rotating basis, a trade
organization or manufacturer of blood,
plasma, or other tissue test kits or
equipment, and a purchaser of blood
and blood products from major hospital
organization.
All ACBSA members are authorized
to receive the prescribed per diem
allowance and reimbursement for travel
expenses that are incurred to attend
meetings and conduct Committeerelated business, in accordance with
Standard Government Travel
Regulations. Individuals who are
appointed to serve as public members
are authorized to also receive a stipend
for attending Committee meetings and
to carry out other Committee-related
business. Individuals who are appointed
to serve as representative members for a
particular interest group or industry are
not authorized to receive a stipend for
the performance of these duties.
This announcement is to solicit
nominations of qualified candidates to
fill positions on the ACBSA that are
scheduled to be vacated in both
membership categories. Qualified
applicants are being sought to represent
the specific interests of the following
blood and blood products industries or
professional organizations: State and
local organizations, advocacy groups,
provider organizations, academic
researchers, private physicians,
scientists, consumer advocates, legal
organizations, one of the two major
distributors of blood, a trade
organization, or manufacturer of blood,
plasma, infectious disease screening
assays or other tissue test kits or
equipment and a major health care
organization that purchases blood and
VerDate Mar<15>2010
15:59 Dec 07, 2011
Jkt 226001
blood products. The positions are
scheduled to be vacated between March
30, 2012 and May 29, 2012.
Nominations
In accordance with the charter,
persons nominated for appointment as
members of the ACBSA should be
among authorities knowledgeable in
blood banking, transfusion medicine,
plasma therapies, transfusion organ and
tissue transplantation, bioethics, and/or
related disciplines. Nominations should
be typewritten. The following
information should be included in the
package of material submitted for each
individual being nominated for
consideration of appointment: (a) The
name, return address, daytime
telephone number, and affiliation(s) of
the individual being nominated, the
basis for the individual’s nomination,
the category for which the individual is
being nominated, and a statement
bearing an original signature of the
nominated individual that, if appointed,
he or she is willing to serve as a member
of the Committee; (b) the name, return
address, and daytime telephone number
at which the nominator may be
contacted. Organizational nominators
must identify a principal contact person
in addition to the contact; and (c) a copy
of a current curriculum vitae or resume
for the nominated individual.
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The letter
from the nominator and certification of
the nominated individual must bear
original signatures; reproduced copies
of these signatures are not acceptable.
The Department of Health and Human
Services is committed to ensuring that
women, minority groups, and physically
challenged individuals are adequately
represented on the Committee.
Nominations of qualified candidates
from these categories are encouraged.
The Department also seeks to have
geographic diversity reflected in the
composition of the Committee.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of the ACBSA are subject to an
ethics review. The ethics review is
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
76733
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
Dated: November 30, 2011.
James J. Berger,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. 2011–31534 Filed 12–7–11; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day-12–12AZ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
World Trade Center Health Program
Enrollment, Appeals, Reimbursement
and Certification—New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The James Zadroga 9/11 Health and
Compensation Act of 2010 (Zadroga
Act), promulgated on December
22,2010, establishes a Federal program
to support health monitoring and
treatment for emergency responders;
recovery and cleanup workers; and
residents, building occupants, and area
workers in New York City who were
directly impacted and adversely affected
by the terrorist attacks of September 11,
2001. In order to provide medical
monitoring and treatment to eligible
individuals, the World Trade Center
(WTC) Health Program will collect
E:\FR\FM\08DEN1.SGM
08DEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
76734
Federal Register / Vol. 76, No. 236 / Thursday, December 8, 2011 / Notices
eligibility and appeals data as well as
information from medical and
prescription pharmaceutical providers.
All responders to the New York City
attack who will be newly seeking
medical monitoring and treatment and
survivors of the attack who were not
covered by the Medical Monitoring and
Treatment Program (MMTP) (for
responders) or the Community Program
(for survivors) prior to January 2, 2011,
may apply to obtain coverage under the
new WTC Health Program. In order to
begin the determination eligibility
process, an enrollment form must be
completed. After an eligibility
application is submitted to the Program,
an unsuccessful applicant has an
opportunity to appeal the decision;
enrolled participants have further
appeal rights. Health care and
prescription pharmaceutical providers
will be required to submit medical
determinations to the WTC Program
Administrator and request
reimbursement.
Data are being collected in order to
determine the eligibility of applicants. If
an applicant is denied enrollment based
on the information provided, the
applicant will receive a letter that gives
the reason for the denial and the
opportunity to appeal the decision.
Once someone is enrolled, he or she
may request approval for reimbursement
of travel if the individual must travel
more than 250 miles to receive
healthcare services. Healthcare
providers and pharmacies will file
claims electronically or by paper form to
be paid for their services. There are
three separate enrollment forms for each
population of responders (Fire
Department of New York City
responders, general responders, and
survivors). The following information
includes the definition of each
population:
‘‘FDNY responder’’ is defined as a
member of the Fire Department of New
York City (whether fire or emergency
personnel, active, or retired) who
participated at least one day in the
rescue and recovery effort at any of the
former World Trade Center sites.
‘‘General Responder’’ is a worker or
volunteer who provided Rescue,
Recovery, Demolition, Debris, Removal
and related support services in the
aftermath of the September 11, 2001
attacks on the World Trade Center but
was not affiliated with the Fire
Department of New York.
‘‘Survivor’’ is a person who was
present in the disaster area in the
aftermath of the September 11, 2001
attacks on the World Trade Center as a
result of his or her work, residence, or
VerDate Mar<15>2010
15:59 Dec 07, 2011
Jkt 226001
attendance at school, childcare, or adult
daycare.
The eligibility application form will
collect general contact information as
well as information regarding the WTC
disaster area experience. Some of the
information provided will be shared
with the Federal Bureau of Investigation
in order to screen an individual against
the terrorist watch list maintained by
the Federal government. This
information will also be shared with the
WTC Program Administrator and will be
kept in a secure manner.
WTC Health Program applicants and
enrolled participants have opportunities
to appeal adverse decisions made by the
WTC Program Administrator. The first
opportunity to appeal arises after a
determination that an applicant does
not meet the eligibility requirements.
Once enrolled in the Program,
participants will also have the
opportunity to appeal a decision not to
certify a WTC-related health condition
or a determination that treatment will
not be authorized as medically
necessary. In the notification letter
explaining the adverse determination,
the applicant will be advised that an
appeal can be requested by submitting
in writing his or her name, contact
information, and an explanation for the
basis of the appeal.
Certain enrolled participants may be
reimbursed for necessary and reasonable
transportation and expenses incident to
the securing of medically necessary
treatment through the nationwide
network if the care involves travel of
more than 250 miles. Individuals
requesting reimbursement must fill out
a 1-page written form requesting such
information as date of travel, distance,
and total expense.
Pharmacies will transmit
reimbursement claims to the WTC
Health Program. The following data
elements will be collected for pharmacy
reimbursement: Pharmacy name,
pharmacy address, drug name,
prescription number, patient name,
patient ID number, and cost. Pharmacies
utilize Electronic Data Interchange (EDI)
processing at the point-of-sale to
transmit claims to the World Trade
Center Health Program (WTCHP). The
EDI transmission conforms to ANSI
standards developed by the National
Council for Prescription Drug Programs.
The information collection burden
occurs as the WTCHP member
information is copied from the
membership card at the point-of-sale.
The EDI transmission occurs in realtime as the prescription transaction is
made.
The Zadroga Act of 2010 requires that
all qualifying WTC-related health
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
conditions or health conditions
medically associated with a WTCrelated health condition be certified by
member to enable reimbursement of
treatment services for care rendered to
that member for a given qualifying
condition(s). To meet the requirement
for certification and maintain continuity
of care for an individual who had been
enrolled in the prior MMTP or
Community Program, the WTC Health
Program physician shall attest that a
prior determination was rendered in the
previous federally sponsored program.
The attestation will include the
physician’s name and signature, the
name of the patient, and the name of the
health condition and its diagnostic
(ICD–9) code.
An individual who is new to the WTC
Health Program must have a certified
WTC-related health condition or health
condition medically associated with
WTC-related health condition to receive
reimbursement for treatment and other
services. If a new medical determination
is being made, the Program clinician
must provide to the WTC Health
Program the patient’s name and program
identification number, the name and
diagnostic code of the health condition,
and a brief narrative explaining the key
exposure findings. The narrative will
include information such as the time
and duration of the individual’s
presence in defined geographic areas (of
exposure), whether the individual was
caught in the dust cloud on September
11, 2001, whether the individual
conducted strenuous activity while in
the exposure zone(s), the individual’s
symptom time course relative to
September 11, 2001, and the reasons a
person might be more likely to get sick
from given exposures (family history or
coexisting medical problems).
A Program physician will also submit
a form to the WTC Health Program
when a member needs medical
treatment for a condition that has not
yet been certified. In that case, the
physician will request authorization to
treat the condition because of the
urgency of the medical scenario. The
physician will sign a form attesting that
a determination was made, and indicate
the patient’s name and the name of the
health condition and its diagnostic
code. Physicians will be compensated
through administrative expenses
invoiced by their respective Clinical
Center of Excellence that is under
contract with the Federal government.
There are no costs to respondents other
than their time. The total estimated
annual burden hours are 19,161.
E:\FR\FM\08DEN1.SGM
08DEN1
76735
Federal Register / Vol. 76, No. 236 / Thursday, December 8, 2011 / Notices
Estimated Annualized Burden Hours
Currently Identified Responders and
Currently Identified Survivors: HHS
estimates that approximately .5 percent
of responders and survivors who had
been enrolled in the prior MMTP or
Community Program (currently
identified responders and survivors), or
290, will be asked to provide the
Program with additional information to
ensure that the individual meets all
criteria to be eligible for the program.
There is no form associated with this
request. Rather, the Program staff will
collect the information provided and
make a note of it in the patient files. We
expect responding to this inquiry to take
no more than 10 minutes.
World Trade Center Health Program
Eligibility Application: Three different
eligibility forms were developed to
address the different criteria for each
group covered by the WTC Health
Program: Fire Department of New York
responders, general responders, and
survivors. We expect that to receive
approximately 4,728 applications per
year. The burden table reflects the
annualized total burden broken into the
three separate applicant groups: we
estimate that 189 Fire Department of
New York (FDNY) responders (4% of
applicants); 2,979 general responders
(63%); and 1,560 survivors (33%) will
submit written applications. The burden
estimates for these three different forms
are: FDNY responders = 95 hours;
general responders = 1,490 hours; and
survivors = 390 hours.
Denial Letter and Appeal
Notification—Eligibility: Of the 4,728
applications we expect to receive per
year, we expect that 10% will fail due
to ineligibility. We further assume that
10% of those individuals, or 47
respondents, will appeal the decision.
The burden estimate is 24 hours
(Attachment F)
Denial Letter and Appeal
Notification—Health Condition: We
expect that program participants
(enrolled responders and survivors) will
request certification for 32,361 health
conditions each year. Of those 32,361,
we expect that .001% (32) of
certification requests will be denied by
the WTC Program Administrator. We
further expect that 95% of denied
certifications, or 30 individuals, will be
appealed. The burden estimate is 15
hours (Attachment G).
Denial Letter and Appeal
Notification—Treatment: Of the
projected 19,596 enrollees who will
receive medical care, it is estimated that
3 percent (588) will appeal a
determination by the WTC Health
Program that the treatment being sought
is not medically necessary. We estimate
that the appeals letter will take no more
than 30 minutes. The burden estimate is
294 hours (Attachment H).
WTC Health Program Medical Travel
Refund Request: WTC responders or
certified eligible survivors who travel
more than 250 miles to a nationwide
network provider for medically
necessary treatment may be provided
necessary and reasonable transportation
and other expenses. These individuals
may submit a travel refund request
form, which should take respondents 10
Number of
respondents
minutes to complete. HHS expects no
more than 10 claims per year. The
burden estimate is 2 hours (Attachment
I).
WTC Health Condition Certification
Request: Physicians will report this data
electronically and on paper. HHS
expects that 2,300 program physicians
will spend approximately 30 minutes
extracting the required elements from
the patient records and transmitting
them to NIOSH, and that approximately
32,361 diagnoses, or 14 per provider,
will be reported to the WTC Health
Program each year. The burden estimate
is 16,100 hours (Attachment J).
Outpatient prescription
pharmaceuticals: Pharmacies will
electronically transmit reimbursement
claims to the WTC Health Program. HHS
estimates that 150 pharmacies will
submit reimbursement claims for 39,192
prescriptions per year, or 261 per
pharmacy; we estimate that each
submission will take 1 minute. The
burden estimate is 653 hours.
Standard Form 3881, for
reimbursement for medically necessary
treatment, monitoring, initial health
evaluations: Standard U.S. Treasury
form SF 3881 (OMB No. 1510–0056)
will be used to gather necessary
information from Program healthcare
providers so that they can be
reimbursed directly from the Treasury
Department. HHS expects that
approximately 200 providers and
provider groups will submit SF 3881,
which is estimated to take 15 minutes
to complete. Providers will submit only
one SF 3881.
Number
responses per
respondent
Average
burden per
response (in
hours)
Total burden
hours
Type of respondent
Form name
Currently Identified Responders and Currently Identified Survivors.
FDNY Responder ..........
No Form ...............................................................
290
1
10/60
48
World Trade Center Health Program FDNY Responder Eligibility Application.
World Trade Center Health Program Responder
Eligibility Application (Other than FDNY).
World Trade Center Health Program Survivor
Eligibility Application.
Denial Letter and Appeal Notification—Eligibility
189
1
30/60
95
2979
1
30/60
1490
1560
1
15/60
390
47
1
30/60
24
Denial Letter and Appeal Notification—Health
Conditions.
30
1
30/60
15
Denial Letter and Appeal Notification—Treatment.
588
1
30/60
294
WTC Health Program Medical Travel Refund
Request.
10
1
10/60
2
WTC Health Condition Certification Request ......
Outpatient prescription pharmaceuticals .............
2,300
150
14
261
30/60
1/60
16,100
653
General Responder .......
mstockstill on DSK4VPTVN1PROD with NOTICES
WTC Survivor ................
FDNY Responder, General Responder and
WTC Survivor.
FDNY Responder, General Responder and
WTC Survivor.
FDNY Responder, General Responder and
WTC Survivor.
FDNY Responder, General Responder and
WTC Survivor.
Physician .......................
Pharmacy .......................
VerDate Mar<15>2010
15:59 Dec 07, 2011
Jkt 226001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
E:\FR\FM\08DEN1.SGM
08DEN1
76736
Federal Register / Vol. 76, No. 236 / Thursday, December 8, 2011 / Notices
Number of
respondents
Type of respondent
Form name
Physician .......................
Standard Form 3881, for reimbursement for
medically necessary treatment, monitoring,
initial health evaluations.
Dated: December 2, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–31562 Filed 12–7–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30–Day–12–11GU]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Survey of Rapid Influenza Diagnostic
Test (RIDT) Practices in LaboratoriesNEW—the Office of Surveillance,
Epidemiology, and Laboratory Services
(OSELS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Survey of Rapid Influenza
Diagnostic Testing Practices in
Laboratories is a national systematic
study investigating rapid influenza
Number
responses per
respondent
200
diagnostic testing practices in clinical
laboratories. The survey will be funded
in full by the Office of Surveillance,
Epidemiology, and Laboratory Services
(OSELS) of the Centers for Disease
Control and Prevention (CDC).
Influenza epidemics usually cause an
average of more than 200,000
hospitalizations and 36,000 deaths per
year in the U.S. Respiratory illnesses
caused by influenza viruses are not
easily differentiated from other
respiratory infections based solely on
symptoms. Also influenza viruses may
adversely affect different
subpopulations. The effective use of
rapid influenza diagnostic testing
practices is an important component of
the differential diagnosis of influenzalike-illness in both inpatient and
outpatient treatment facilities. Test
results are used for making decisions
about antiviral vs. antibiotic use, and in
making admission or discharge
decisions. In many cases, rapid
influenza tests are the only tests that can
provide results while the patient is still
present in the facility. Thus, the
appropriate use of the tests, and
interpretation of test results is critical to
the treatment and control of influenza.
More than a dozen rapid tests have been
approved by the U.S. Food and Drug
Administration and are in widespread
use. The reliability of rapid influenza
tests is influenced by the individual test
product used and the setting. Reported
sensitivities range from 10–75%; while
the median specificities reported are
90–95%. Other factors influencing
accuracy are the stage (or duration) of
illness when the diagnostic specimen is
collected, type and adequacy of the
specimen collected, variability in user
technique for specimen collection or
assay performance, and disease activity
in the community. Given these and
1
Average
burden per
response (in
hours)
Total burden
hours
15/60
50
other collective findings, it is imperative
for public health and for response
planning that CDC develops sectorspecific guidance and effective outreach
to the clinicians on appropriate use of
RIDT in their practices.
Previous studies by CDC of outpatient
facilities showed that clinical
laboratories usually perform the rapid
tests for emergency departments, and
provide results for both inpatient and
outpatient treatment. Thus,
understanding the use of rapid
influenza testing in clinical laboratories,
how the laboratories report results to
emergency departments and treatment
facilities and health departments, and
what quality assurance practices are
used will guide future efforts of the CDC
to develop appropriate influenza testing
guidelines and sector-specific training
materials for clinicians and improve
health outcomes of the American
public.
The survey covers basic laboratory
demographic characteristics, specimen
collection and processing, testing
practices, reporting of results to
emergency departments and other
treatment facilities, reporting results to
health departments, quality assurance
practices, and methods of receiving
updated influenza-related information.
The majority of the questions request
information about laboratory influenza
testing practices.
To date, no systematic study has been
conducted to investigate how
laboratories use these tests, how they
report results, or how they interact with
outpatient treatment facilities. The
survey will be conducted on a national
sample of clinical laboratories. There
are no costs to respondents except their
time. The total estimated annual burden
hours are 1020.
mstockstill on DSK4VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Clinical Laboratory Supervisors ......................
Survey of Rapid Influenza Diagnostic Test
Practices in Laboratories.
VerDate Mar<15>2010
15:59 Dec 07, 2011
Jkt 226001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
E:\FR\FM\08DEN1.SGM
2040
08DEN1
Number of
responses per
respondent
1
Avg. burden
per response
(in hrs)
30/60
Agencies
[Federal Register Volume 76, Number 236 (Thursday, December 8, 2011)]
[Notices]
[Pages 76733-76736]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-31562]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-12-12AZ]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
World Trade Center Health Program Enrollment, Appeals,
Reimbursement and Certification--New--National Institute for
Occupational Safety and Health (NIOSH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The James Zadroga 9/11 Health and Compensation Act of 2010 (Zadroga
Act), promulgated on December 22,2010, establishes a Federal program to
support health monitoring and treatment for emergency responders;
recovery and cleanup workers; and residents, building occupants, and
area workers in New York City who were directly impacted and adversely
affected by the terrorist attacks of September 11, 2001. In order to
provide medical monitoring and treatment to eligible individuals, the
World Trade Center (WTC) Health Program will collect
[[Page 76734]]
eligibility and appeals data as well as information from medical and
prescription pharmaceutical providers.
All responders to the New York City attack who will be newly
seeking medical monitoring and treatment and survivors of the attack
who were not covered by the Medical Monitoring and Treatment Program
(MMTP) (for responders) or the Community Program (for survivors) prior
to January 2, 2011, may apply to obtain coverage under the new WTC
Health Program. In order to begin the determination eligibility
process, an enrollment form must be completed. After an eligibility
application is submitted to the Program, an unsuccessful applicant has
an opportunity to appeal the decision; enrolled participants have
further appeal rights. Health care and prescription pharmaceutical
providers will be required to submit medical determinations to the WTC
Program Administrator and request reimbursement.
Data are being collected in order to determine the eligibility of
applicants. If an applicant is denied enrollment based on the
information provided, the applicant will receive a letter that gives
the reason for the denial and the opportunity to appeal the decision.
Once someone is enrolled, he or she may request approval for
reimbursement of travel if the individual must travel more than 250
miles to receive healthcare services. Healthcare providers and
pharmacies will file claims electronically or by paper form to be paid
for their services. There are three separate enrollment forms for each
population of responders (Fire Department of New York City responders,
general responders, and survivors). The following information includes
the definition of each population:
``FDNY responder'' is defined as a member of the Fire Department of
New York City (whether fire or emergency personnel, active, or retired)
who participated at least one day in the rescue and recovery effort at
any of the former World Trade Center sites.
``General Responder'' is a worker or volunteer who provided Rescue,
Recovery, Demolition, Debris, Removal and related support services in
the aftermath of the September 11, 2001 attacks on the World Trade
Center but was not affiliated with the Fire Department of New York.
``Survivor'' is a person who was present in the disaster area in
the aftermath of the September 11, 2001 attacks on the World Trade
Center as a result of his or her work, residence, or attendance at
school, childcare, or adult daycare.
The eligibility application form will collect general contact
information as well as information regarding the WTC disaster area
experience. Some of the information provided will be shared with the
Federal Bureau of Investigation in order to screen an individual
against the terrorist watch list maintained by the Federal government.
This information will also be shared with the WTC Program Administrator
and will be kept in a secure manner.
WTC Health Program applicants and enrolled participants have
opportunities to appeal adverse decisions made by the WTC Program
Administrator. The first opportunity to appeal arises after a
determination that an applicant does not meet the eligibility
requirements.
Once enrolled in the Program, participants will also have the
opportunity to appeal a decision not to certify a WTC-related health
condition or a determination that treatment will not be authorized as
medically necessary. In the notification letter explaining the adverse
determination, the applicant will be advised that an appeal can be
requested by submitting in writing his or her name, contact
information, and an explanation for the basis of the appeal.
Certain enrolled participants may be reimbursed for necessary and
reasonable transportation and expenses incident to the securing of
medically necessary treatment through the nationwide network if the
care involves travel of more than 250 miles. Individuals requesting
reimbursement must fill out a 1-page written form requesting such
information as date of travel, distance, and total expense.
Pharmacies will transmit reimbursement claims to the WTC Health
Program. The following data elements will be collected for pharmacy
reimbursement: Pharmacy name, pharmacy address, drug name, prescription
number, patient name, patient ID number, and cost. Pharmacies utilize
Electronic Data Interchange (EDI) processing at the point-of-sale to
transmit claims to the World Trade Center Health Program (WTCHP). The
EDI transmission conforms to ANSI standards developed by the National
Council for Prescription Drug Programs. The information collection
burden occurs as the WTCHP member information is copied from the
membership card at the point-of-sale. The EDI transmission occurs in
real-time as the prescription transaction is made.
The Zadroga Act of 2010 requires that all qualifying WTC-related
health conditions or health conditions medically associated with a WTC-
related health condition be certified by member to enable reimbursement
of treatment services for care rendered to that member for a given
qualifying condition(s). To meet the requirement for certification and
maintain continuity of care for an individual who had been enrolled in
the prior MMTP or Community Program, the WTC Health Program physician
shall attest that a prior determination was rendered in the previous
federally sponsored program. The attestation will include the
physician's name and signature, the name of the patient, and the name
of the health condition and its diagnostic (ICD-9) code.
An individual who is new to the WTC Health Program must have a
certified WTC-related health condition or health condition medically
associated with WTC-related health condition to receive reimbursement
for treatment and other services. If a new medical determination is
being made, the Program clinician must provide to the WTC Health
Program the patient's name and program identification number, the name
and diagnostic code of the health condition, and a brief narrative
explaining the key exposure findings. The narrative will include
information such as the time and duration of the individual's presence
in defined geographic areas (of exposure), whether the individual was
caught in the dust cloud on September 11, 2001, whether the individual
conducted strenuous activity while in the exposure zone(s), the
individual's symptom time course relative to September 11, 2001, and
the reasons a person might be more likely to get sick from given
exposures (family history or coexisting medical problems).
A Program physician will also submit a form to the WTC Health
Program when a member needs medical treatment for a condition that has
not yet been certified. In that case, the physician will request
authorization to treat the condition because of the urgency of the
medical scenario. The physician will sign a form attesting that a
determination was made, and indicate the patient's name and the name of
the health condition and its diagnostic code. Physicians will be
compensated through administrative expenses invoiced by their
respective Clinical Center of Excellence that is under contract with
the Federal government. There are no costs to respondents other than
their time. The total estimated annual burden hours are 19,161.
[[Page 76735]]
Estimated Annualized Burden Hours
Currently Identified Responders and Currently Identified Survivors:
HHS estimates that approximately .5 percent of responders and survivors
who had been enrolled in the prior MMTP or Community Program (currently
identified responders and survivors), or 290, will be asked to provide
the Program with additional information to ensure that the individual
meets all criteria to be eligible for the program. There is no form
associated with this request. Rather, the Program staff will collect
the information provided and make a note of it in the patient files. We
expect responding to this inquiry to take no more than 10 minutes.
World Trade Center Health Program Eligibility Application: Three
different eligibility forms were developed to address the different
criteria for each group covered by the WTC Health Program: Fire
Department of New York responders, general responders, and survivors.
We expect that to receive approximately 4,728 applications per year.
The burden table reflects the annualized total burden broken into the
three separate applicant groups: we estimate that 189 Fire Department
of New York (FDNY) responders (4% of applicants); 2,979 general
responders (63%); and 1,560 survivors (33%) will submit written
applications. The burden estimates for these three different forms are:
FDNY responders = 95 hours; general responders = 1,490 hours; and
survivors = 390 hours.
Denial Letter and Appeal Notification--Eligibility: Of the 4,728
applications we expect to receive per year, we expect that 10% will
fail due to ineligibility. We further assume that 10% of those
individuals, or 47 respondents, will appeal the decision. The burden
estimate is 24 hours (Attachment F)
Denial Letter and Appeal Notification--Health Condition: We expect
that program participants (enrolled responders and survivors) will
request certification for 32,361 health conditions each year. Of those
32,361, we expect that .001% (32) of certification requests will be
denied by the WTC Program Administrator. We further expect that 95% of
denied certifications, or 30 individuals, will be appealed. The burden
estimate is 15 hours (Attachment G).
Denial Letter and Appeal Notification--Treatment: Of the projected
19,596 enrollees who will receive medical care, it is estimated that 3
percent (588) will appeal a determination by the WTC Health Program
that the treatment being sought is not medically necessary. We estimate
that the appeals letter will take no more than 30 minutes. The burden
estimate is 294 hours (Attachment H).
WTC Health Program Medical Travel Refund Request: WTC responders or
certified eligible survivors who travel more than 250 miles to a
nationwide network provider for medically necessary treatment may be
provided necessary and reasonable transportation and other expenses.
These individuals may submit a travel refund request form, which should
take respondents 10 minutes to complete. HHS expects no more than 10
claims per year. The burden estimate is 2 hours (Attachment I).
WTC Health Condition Certification Request: Physicians will report
this data electronically and on paper. HHS expects that 2,300 program
physicians will spend approximately 30 minutes extracting the required
elements from the patient records and transmitting them to NIOSH, and
that approximately 32,361 diagnoses, or 14 per provider, will be
reported to the WTC Health Program each year. The burden estimate is
16,100 hours (Attachment J).
Outpatient prescription pharmaceuticals: Pharmacies will
electronically transmit reimbursement claims to the WTC Health Program.
HHS estimates that 150 pharmacies will submit reimbursement claims for
39,192 prescriptions per year, or 261 per pharmacy; we estimate that
each submission will take 1 minute. The burden estimate is 653 hours.
Standard Form 3881, for reimbursement for medically necessary
treatment, monitoring, initial health evaluations: Standard U.S.
Treasury form SF 3881 (OMB No. 1510-0056) will be used to gather
necessary information from Program healthcare providers so that they
can be reimbursed directly from the Treasury Department. HHS expects
that approximately 200 providers and provider groups will submit SF
3881, which is estimated to take 15 minutes to complete. Providers will
submit only one SF 3881.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Currently Identified Responders and Currently No Form................................ 290 1 10/60 48
Identified Survivors.
FDNY Responder................................. World Trade Center Health Program FDNY 189 1 30/60 95
Responder Eligibility Application.
General Responder.............................. World Trade Center Health Program 2979 1 30/60 1490
Responder Eligibility Application
(Other than FDNY).
WTC Survivor................................... World Trade Center Health Program 1560 1 15/60 390
Survivor Eligibility Application.
FDNY Responder, General Responder and WTC Denial Letter and Appeal Notification-- 47 1 30/60 24
Survivor. Eligibility.
FDNY Responder, General Responder and WTC Denial Letter and Appeal Notification-- 30 1 30/60 15
Survivor. Health Conditions.
FDNY Responder, General Responder and WTC Denial Letter and Appeal Notification-- 588 1 30/60 294
Survivor. Treatment.
FDNY Responder, General Responder and WTC WTC Health Program Medical Travel 10 1 10/60 2
Survivor. Refund Request.
Physician...................................... WTC Health Condition Certification 2,300 14 30/60 16,100
Request.
Pharmacy....................................... Outpatient prescription pharmaceuticals 150 261 1/60 653
[[Page 76736]]
Physician...................................... Standard Form 3881, for reimbursement 200 1 15/60 50
for medically necessary treatment,
monitoring, initial health evaluations.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: December 2, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-31562 Filed 12-7-11; 8:45 am]
BILLING CODE 4163-18-P